Literature DB >> 13975274

A rapid method for assessing drug inhibition of feeding behavior.

A P ROSZKOWSKI, N M KELLEY.   

Abstract

Keywords:  AMPHETAMINE; APPETITE; DEXTRO AMPHETAMINE; DIETHYLPROPION; METHAMPHETAMINE; METHYLPHENIDATE; OXAZOLES; PHENMETRAZINE

Mesh：

Substances：

Year:  1963        PMID： 13975274

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').

Authors:  Simon D Brandt; Michael H Baumann; John S Partilla; Pierce V Kavanagh; John D Power; Brian Talbot; Brendan Twamley; Olivia Mahony; John O'Brien; Simon P Elliott; Roland P Archer; Julian Patrick; Kuldip Singh; Nicola M Dempster; Simon H Cosbey
Journal:  Drug Test Anal       Date:  2014-05-19       Impact factor: 3.345

Review 2.  [Weight reduction by diet, drugs and operative methods in obesity].

Authors:  H Liebermeister
Journal:  Klin Wochenschr       Date:  1971-02

3.  Swimming capacity of mice after prolonged treatment with psychostimulants. II. Effect of methamphetamine on swimming performance and availability of metabolic substrates.

Authors:  C J Estler; M C Gabrys
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

Review 4.  Cocaine adulteration.

Authors:  Oliver Kudlacek; Tina Hofmaier; Anton Luf; Felix P Mayer; Thomas Stockner; Constanze Nagy; Marion Holy; Michael Freissmuth; Rainer Schmid; Harald H Sitte
Journal:  J Chem Neuroanat       Date:  2017-06-12       Impact factor: 3.097

5.  Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.

Authors:  Tina Hofmaier; Anton Luf; Amir Seddik; Thomas Stockner; Marion Holy; Michael Freissmuth; Gerhard F Ecker; Rainer Schmid; Harald H Sitte; Oliver Kudlacek
Journal:  Neurochem Int       Date:  2013-12-01       Impact factor: 4.297
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.